Siegfried Holding
Philipp Kurzweil, CFA, currently serves as Head of Finance and Controlling, along with holding the positions of Senior Manager and Manager of Strategy and M&A at Siegfried since 2019. Prior experience includes roles as Senior Consultant and Consultant in M&A at EY from 2016 to 2019, as well as an internship in Corporate Finance & M&A at Proventis Partners GmbH and an internship in Mergers & Acquisitions at Commerzbank AG in 2012. Philipp Kurzweil holds a Master of Arts in Accounting and Finance from the University of St.Gallen and a Bachelor of Arts in Economics from the same institution. Additional educational pursuits include a CAS in Pharmaceuticals from ETH Zürich and an exchange semester in the Post Graduate Programme in Management at the Indian School of Business.
This person is not in any teams
This person is not in any offices
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.